Thomas Baumert
Founder University of Strasbourg
Thomas F. Baumert, MD, is Director of the Inserm Institute for Translational Medicine and Professor of Medicine at the University of Strasbourg. A board-certified internist and gastroenterologist, he trained at Harvard, NIH, and DKFZ. His research focuses on innovative therapies for fibrosis and cancer using liver disease as a model. He has authored 400+ publications, holds 25+ patents, and founded Alentis Therapeutics. His work is supported by the EU, NIH, and industry, and has earned him numerous awards including the Prix Galien and Inserm Research Award.
Seminars
Wednesday 3rd December 2025
Patient-Derived Tumour Spheroids to Model the Tumour Microenvironment & Accelerate Drug Development
2:00 pm
- Applying patient-derived tumour spheroids to model the tumour immune microenvironment including T cell infiltration and function, tumour fibrosis, CAF and endothelial cell biology
- Modelling the specific treatment response of compounds on the patient tumour immune environment and cancer epithelial cells using single cell RNASeq and proteomics
- Understanding how patient-derived tumour spheroids accelerate drug development using liver and pancreatic cancer as examples
